Case Presentation by Minisha Sood MD, Chief Resident
Please review the posting of our prior CPC here.
When you’re ready you can download the CPC Answer.
In an open-label randomized control study of patients with chronic hepatitis C genotype 1b and high viral load on pegylated interferon/ribavirin combination therapy, Kondo et al found that sustained virological response (SVR) rate was significantly higher in the fluvastatin group than in the non fluvastatin group (63.0% vs 41.7%, P = 0.0422). In addition, male gender and major genotype IL28B single nucleotide polymorphisms were both independent predictors for SVR among patients taking fluvastatin with their hepatitis C medications.
The patient perspective in all it's gory detail, from Andy Borowitz...hilarious http://t.co/qxgrvgEYNU
Primecuts – This Week In The Journals http://t.co/K68aOjE9FP
Nut consumption and associated mortality - the animated version. Hawaii's macademia nut fans are crying http://t.co/FiNPAIybpK
NYTimes article - The Vaccination Effect. http://t.co/zXMjnoQZ4Q
Happy Thanksgiving http://t.co/AcEWjRhk0H